With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Medtronic stock slumped early Tuesday despite beating fiscal second-quarter expectations after a supplier issue impacted its cardiac ablation division. Please watch the video at Investors.com - How To ...

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

New research suggests that a procedure now regarded as Plan B when patients have episodes of rapid heartbeat after a heart ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

From its cardiovascular divisions, Medtronic brought in $3.1 billion for an increase of 6.1%—driven in part by the launches ...

When Tara Garcia was born, her skin was tinted blue. This meant a lack of oxygen in her body. Doctors told her parents the ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and stroke if left untreated.

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.